Literature DB >> 33970839

SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies.

Zhao-Zhong Chong1,2, Nizar Souayah1.   

Abstract

The new coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can present neurological symptoms and induce neurological complications. The involvement in both the central and peripheral nervous systems in COVID-19 patients has been associated with direct invasion of the virus and the induction of cytokine storm. This review discussed the pathways for the virus invasion into the nervous system and characterized the SARS-CoV-2 induced cytokine storm. In addition, the mechanisms underlying the immune responses and cytokine storm induction after SARS-CoV-2 infection were also discussed. Although some neurological symptoms are mild and disappear after recovery from infection, some severe neurological complications contribute to the mortality of COVID-19 patients. Therefore, the insight into the cause of SARS-CoV-2 induced cytokine storm in context with neurological complications will formulate the novel management of the disease and also further identify new therapeutic targets for COVID-19. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  COVID-19; Cytokine; Janus kinase; Toll-like receptors; interferon; neurological complications

Mesh:

Year:  2022        PMID: 33970839     DOI: 10.2174/0929867328666210506161543

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  2 in total

Review 1.  Neurological manifestations in patients with COVID-19: A systematic review and meta-analysis.

Authors:  Marzie Mahdizade Ari; Mohamad Hosein Mohamadi; Negar Shadab Mehr; Sajjad Abbasimoghaddam; Amirhosein Shekartabar; Mohsen Heidary; Saeed Khoshnood
Journal:  J Clin Lab Anal       Date:  2022-04-06       Impact factor: 3.124

2.  Identification of novel off targets of baricitinib and tofacitinib by machine learning with a focus on thrombosis and viral infection.

Authors:  Maria L Faquetti; Francesca Grisoni; Petra Schneider; Gisbert Schneider; Andrea M Burden
Journal:  Sci Rep       Date:  2022-05-12       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.